Contact
Please use this form to send email to PR contact of this press release:
Supernus Announces FDA Approval of sNDA to Expand Oxtellar XR® Label to Include Monotherapy
TO:
Please use this form to send email to PR contact of this press release:
Supernus Announces FDA Approval of sNDA to Expand Oxtellar XR® Label to Include Monotherapy
TO: